SEARCH

SEARCH BY CITATION

References

  • 1
    Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 13591363.
  • 2
    Hadengue A, Benhayoun MK, Lebrec D, Benamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100: 520528.
  • 3
    Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestation. J Am Coll Cardiol 1991; 17: 492498.
  • 4
    De Wolf AM, Scott VL, Gasior T, Kang Y. Pulmonary hypertension and liver transplantation. Anesthesiology 1993; 78: 213214.
  • 5
    Cheng EY, Woehlck HJ. Pulmonary artery hypertension complicating anesthesia for liver transplantation. Anesthesiology 1992; 77: 389392.
  • 6
    Prager MC, Cauldwell CA, Ascher NL, Roberts JP, Wolfe CL. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology 1992; 77: 375378.
  • 7
    Perelmuter B, Whitfield JM, Ramsay MAE, Lynch K, Weisner D, Nguyen AT, Hein HAT, et al. Nitric oxide use in neonatal and adult patients at Baylor University Medical Center. BUMC Proceedings 1996; 9: 39.
  • 8
    Carnes KS, Anderson GM, Head DE, Miller MJ, Ramsay MAE. Nitric oxide: no laughing matter. Baylor University Medical Center Proceedings 1994; 7: 3137.
  • 9
    Morris GN, Rich GF, Johns RA. Exogenous inhaled nitric oxide as a selective pulmonary vasodilator. Semin Anesthesia 1996; 15: 4760.
  • 10
    Mandell MS, Duke J. Nitric oxide reduces pulmonary hypertension during hepatic transplantation. Anesthesiology 1994; 81: 15381592.
  • 11
    De Wolf AM, Gasior T, Kang Y. Pulmonary hypertension in a patient undergoing liver transplantation. Transplant Proc 1991; 23: 20002001.
  • 12
    Rich S, Brundage BH, Levy PS. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation 1985; 71: 11911196.
  • 13
    Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776778.
  • 14
    Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994; 20: 13431350.
  • 15
    Matsumoto A, Ogura K, Hirata Y, Kakoki M, Watanabe F, Takenaka K, Shiratori Y, et al. Increased nitric oxide in the exhaled air of patients with decompensated liver disease. Ann Intern Med 1994; 123: 110113.
  • 16
    Murali S, Kormos RL, Uretsky BF, Schecter D, Reddy PS, Hardesty RL, Ruffner RJ, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993; 126: 896904.
  • 17
    Kieler-Jensen N, Ricksten S-E, Stenqvest O, Bergh C-H, Lindelov B, Wennmalm A, Waagstein F, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994; 13: 366375.
  • 18
    McGregor M, Sniderman A. On pulmonary vascular resistance: the need for more precise definition. Am J Cardiol 1985; 55: 217221.
  • 19
    Holmgren A, Jonsson B, Sjostrand T. Circulatory data in normal subjects at rest and during exercise in recumbent position, with special reference to the stroke volume at different work intensities. Acta Physiol Scand 1960; 49: 343363.